AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $504 | -16.1% | 10,967 | +4.8% | 0.00% | -25.0% |
| Q2 2023 | $601 | +34.5% | 10,460 | -12.2% | 0.00% | +33.3% |
| Q1 2023 | $447 | -59.6% | 11,911 | -69.8% | 0.00% | -62.5% |
| Q4 2022 | $1,107 | -99.9% | 39,494 | -19.7% | 0.01% | -20.0% |
| Q3 2022 | $1,381,000 | +456.9% | 49,156 | +590.5% | 0.01% | +400.0% |
| Q2 2022 | $248,000 | -12.7% | 7,119 | -10.1% | 0.00% | +100.0% |
| Q1 2022 | $284,000 | +17.4% | 7,917 | -36.9% | 0.00% | -50.0% |
| Q4 2017 | $242,000 | +195.1% | 12,555 | +148.2% | 0.00% | +100.0% |
| Q2 2016 | $82,000 | +64.0% | 5,059 | +21.7% | 0.00% | – |
| Q1 2016 | $50,000 | +13.6% | 4,158 | +33.0% | 0.00% | – |
| Q4 2015 | $44,000 | -8.3% | 3,126 | -24.1% | 0.00% | – |
| Q3 2015 | $48,000 | +108.7% | 4,120 | +215.7% | 0.00% | – |
| Q2 2015 | $23,000 | – | 1,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRIESS ASSOCIATES LLC | 97,760 | $3,401,000 | 5.68% |
| Nantahala Capital Management | 1,000,000 | $34,790,000 | 1.74% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 341,294 | $11,874,000 | 1.52% |
| Portolan Capital Management | 274,889 | $9,563,000 | 0.96% |
| Quantedge Capital Pte Ltd | 121,500 | $4,227,000 | 0.85% |
| SHAKER INVESTMENTS LLC/OH | 37,117 | $1,291,000 | 0.82% |
| GLOBEFLEX CAPITAL L P | 72,253 | $2,514,000 | 0.61% |
| EAM Investors, LLC | 68,855 | $2,395,000 | 0.58% |
| Hillsdale Investment Management Inc. | 197,738 | $6,879,000 | 0.55% |
| Capital Impact Advisors, LLC | 13,835 | $481,000 | 0.44% |